Clinical course and pathologic features of conjunctival non-Hodgkin's lymphoma. A report of six cases

Graefes Arch Clin Exp Ophthalmol. 1990;228(3):246-51. doi: 10.1007/BF00920029.

Abstract

Six patients with conjunctival non-Hodgkin's lymphoma (NHL) were evaluated. In all six cases the conjunctiva was the primary site of clinical presentation; four cases involved low-grade malignancy and two, intermediate-grade malignancy, according to the International Working Formulation. The disease developed within a short period of time to stage IV. The poor response to therapy revealed a worse prognosis than would be expected according to the histopathologic classification. Four of the six patients died of NHL, three of them within 15 months. Comparison of these 6 cases with a group of 15 patients with orbital NHL revealed a much better prognosis in the latter patients. In spite of the fact that 4 of the 15 orbital cases showed NHL of high-grade malignancy, only 2 of them died of the lymphoma. Therefore, conjunctival NHL requires a fast and adequate diagnostic and therapeutic approach.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Conjunctival Neoplasms / mortality
  • Conjunctival Neoplasms / pathology*
  • Conjunctival Neoplasms / therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphoma, Non-Hodgkin / mortality
  • Lymphoma, Non-Hodgkin / pathology*
  • Lymphoma, Non-Hodgkin / therapy
  • Male
  • Middle Aged
  • Orbital Neoplasms / pathology
  • Prognosis

Substances

  • Adrenal Cortex Hormones
  • Anti-Bacterial Agents